Objectives: Preterm neonates are at risk of symptomatic postnatal cytomegalovirus (pCMV) acquired from CMV-positive breast milk intake. This study ascertained the proportion of mothers delivering at ≤ 32 weeks' gestation with CMV lactatia.
Methods: This prospective study included mother-infant dyads delivered at ≤ 32 weeks' gestation. CMV was detected in breast milk by quantitative DNA PCR. For the proportion of neonates who tested positive for CMV DNA (urine or blood) at 4-6 weeks of age, clinical outcomes were also measured. CMV load > 42.5 copies/mL was considered positive. Virologic (breast milk and infant blood/urine CMV PCR) and clinical correlates were evaluated.
Results: Out of the 93 mothers whose fresh breast milk was tested, 50 (53.7%, 95%CI 42.3, 55.9%) were positive for CMV. Out of 43 infants who were tested for CMV in blood or urine at 4-6 weeks of postnatal age, 10 (23%, 95%CI 18.1, 28.6%) turned positive. Significant differences were noted in the duration of respiratory support [47.5 (30, 73) vs 7 (3, 30) days; P = 0.002] and hospital stay [86.5 (80, 98) vs 51 (31, 65) days, P < 0.001] between CMV positive and negative infants. CMV-positive status was not an independent risk factor for bronchopulmonary dysplasia [aOR 5.3 (95%CI 0.9-31.0)] and retinopathy of prematurity requiring therapy [aOR 17.3 (95%CI 0.9-194.2)].
Conclusion: 53.7% of mothers delivering prematurely had CMV lactatia; 23% of their infants were positive for CMV at 4-6 weeks of age.
{"title":"Cytomegalovirus Secretion in Breast Milk of Mothers Delivering at ≤ 32 Weeks' Gestation: A Prospective Observational Study.","authors":"Zubair Ahmad Bhat, Mohamed Muneer Varikkottil, Femitha Pournami, Ajai Kumar Prithvi, Naveen Jain","doi":"10.1007/s13312-025-00203-5","DOIUrl":"10.1007/s13312-025-00203-5","url":null,"abstract":"<p><strong>Objectives: </strong>Preterm neonates are at risk of symptomatic postnatal cytomegalovirus (pCMV) acquired from CMV-positive breast milk intake. This study ascertained the proportion of mothers delivering at ≤ 32 weeks' gestation with CMV lactatia.</p><p><strong>Methods: </strong>This prospective study included mother-infant dyads delivered at ≤ 32 weeks' gestation. CMV was detected in breast milk by quantitative DNA PCR. For the proportion of neonates who tested positive for CMV DNA (urine or blood) at 4-6 weeks of age, clinical outcomes were also measured. CMV load > 42.5 copies/mL was considered positive. Virologic (breast milk and infant blood/urine CMV PCR) and clinical correlates were evaluated.</p><p><strong>Results: </strong>Out of the 93 mothers whose fresh breast milk was tested, 50 (53.7%, 95%CI 42.3, 55.9%) were positive for CMV. Out of 43 infants who were tested for CMV in blood or urine at 4-6 weeks of postnatal age, 10 (23%, 95%CI 18.1, 28.6%) turned positive. Significant differences were noted in the duration of respiratory support [47.5 (30, 73) vs 7 (3, 30) days; P = 0.002] and hospital stay [86.5 (80, 98) vs 51 (31, 65) days, P < 0.001] between CMV positive and negative infants. CMV-positive status was not an independent risk factor for bronchopulmonary dysplasia [aOR 5.3 (95%CI 0.9-31.0)] and retinopathy of prematurity requiring therapy [aOR 17.3 (95%CI 0.9-194.2)].</p><p><strong>Conclusion: </strong>53.7% of mothers delivering prematurely had CMV lactatia; 23% of their infants were positive for CMV at 4-6 weeks of age.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"107-112"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-09DOI: 10.1007/s13312-025-00192-5
Susy Joseph, Veena Anand, G K Libu, A S Ajith Krishnan
Objective: To compare module-based versus conventional lectures for undergraduate teaching in pediatrics.
Methods: This quasi-experimental study was conducted among phase III part II MBBS students during their pediatric posting at a tertiary care teaching center in Southern India. Fifty students each in the experimental and control group were taught using module-based and conventional lectures, respectively. The learning outcome was evaluated by pre-, and post-test scores and analyzed by 'paired t test', 'unpaired t test' and 'repeated measure ANOVA'. Perception was assessed using five-point Likert scale.
Results: The gain of marks for module-based teaching was statistically significant compared to conventional lecture (P < 0.001). Regarding perception, 72% of students 'strongly agreed' (40%) and 'agreed' (32%) to the different characteristics of modular teaching whereas in conventional lecture, 34% were neutral, 32% disagreed, and 12% strongly disagreed.
Conclusion: The knowledge outcome and perception level in module-based teaching are superior to that of conventional lectures.
{"title":"Module-Based Teaching Versus Conventional Lectures in Undergraduate Teaching in Pediatrics: A Quasi-Experimental Study.","authors":"Susy Joseph, Veena Anand, G K Libu, A S Ajith Krishnan","doi":"10.1007/s13312-025-00192-5","DOIUrl":"10.1007/s13312-025-00192-5","url":null,"abstract":"<p><strong>Objective: </strong>To compare module-based versus conventional lectures for undergraduate teaching in pediatrics.</p><p><strong>Methods: </strong>This quasi-experimental study was conducted among phase III part II MBBS students during their pediatric posting at a tertiary care teaching center in Southern India. Fifty students each in the experimental and control group were taught using module-based and conventional lectures, respectively. The learning outcome was evaluated by pre-, and post-test scores and analyzed by 'paired t test', 'unpaired t test' and 'repeated measure ANOVA'. Perception was assessed using five-point Likert scale.</p><p><strong>Results: </strong>The gain of marks for module-based teaching was statistically significant compared to conventional lecture (P < 0.001). Regarding perception, 72% of students 'strongly agreed' (40%) and 'agreed' (32%) to the different characteristics of modular teaching whereas in conventional lecture, 34% were neutral, 32% disagreed, and 12% strongly disagreed.</p><p><strong>Conclusion: </strong>The knowledge outcome and perception level in module-based teaching are superior to that of conventional lectures.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"92-99"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
For neonates with congenital diaphragmatic hernia (CDH), the challenges start immediately after birth. Respiratory distress and hemodynamic compromise set in with the herniation of the contents of the abdomen into the thoracic cavity. Though definitive surgical correction and long-term follow-up are required, the immediate postnatal stabilization is of paramount importance. Depending on the extent of herniation, the associated physiological impairment is variable. With extensive research over the past few decades and a better understanding of the disease physiology, coupled with newer modalities in management, various multi-institutional bodies have proposed clinical practice guidelines. This study aims to compare these guidelines for the management of CDH neonates and to understand their implications for resource-poor settings.
{"title":"Guidelines for the Medical Management of Congenital Diaphragmatic Hernia: Implications for Resource-limited Settings.","authors":"Kshitij Aviraj Singh, Keshav Kumar Pathak, Richie Dalai","doi":"10.1007/s13312-025-00240-0","DOIUrl":"10.1007/s13312-025-00240-0","url":null,"abstract":"<p><p>For neonates with congenital diaphragmatic hernia (CDH), the challenges start immediately after birth. Respiratory distress and hemodynamic compromise set in with the herniation of the contents of the abdomen into the thoracic cavity. Though definitive surgical correction and long-term follow-up are required, the immediate postnatal stabilization is of paramount importance. Depending on the extent of herniation, the associated physiological impairment is variable. With extensive research over the past few decades and a better understanding of the disease physiology, coupled with newer modalities in management, various multi-institutional bodies have proposed clinical practice guidelines. This study aims to compare these guidelines for the management of CDH neonates and to understand their implications for resource-poor settings.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"126-132"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-08-06DOI: 10.1007/s13312-025-00154-x
Anshuman Saha, A P Anila, K V Pavan, Arpana Iyengar, Anil Vasudevan
Objectives: To correlate the inferior vena cava/aorta diameter (IVC/Ao index) in children with nephrotic syndrome with clinical indicators of volume status, and to compare the IVC/Ao index between children in relapse and in remission.
Methods: This prospective longitudinal study included children aged 2-18 years presenting with relapsed nephrotic syndrome. Low intravascular volume status was diagnosed if two of the three criteria (tachycardia, hypotension, prolonged capillary filling time) were present. Sonographic measurements of the IVC and aorta diameter were obtained by a single observer at recruitment and after achieving remission.
Results: One hundred and three children (73 boys) with a median (Q1, Q3) age 72 (24, 216) months were recruited. 26 (25%) children had low intravascular volume at recruitment. The mean (SD) IVC/Ao index was lower in low volume status compared to normal volume status [0.74 (0.2) vs 0.83 (0.1); P = 0.090]. The correlation between IVC/Ao index and heart rate (r = -0.29, P = 0.003) and mean arterial pressure (r = 0.23, P = 0.018) was weak. IVC/Ao index was not an independent predictor of volume status (OR = 0.04, P = 0.331). The mean (SD) IVC/Ao index increased significantly from when in relapse to remission [0.94 (0.1) vs 1.05 (0.2), respectively; P = 0.001].
Conclusions: The IVC/Ao index was lower in relapse than in remission, and did not predict low intravascular volume status independently.
目的:探讨肾病综合征患儿下腔静脉/主动脉直径(IVC/Ao指数)与容积状态临床指标的相关性,比较复发期和缓解期患儿的IVC/Ao指数。方法:这项前瞻性纵向研究纳入了2-18岁的复发性肾病综合征患儿。如果三个标准(心动过速,低血压,毛细血管充盈时间延长)中的两个存在,则诊断为血管内容量低。超声测量下腔静脉和主动脉直径由一个单一的观察者在恢复和达到缓解后获得。结果:招募了103名儿童(73名男孩),中位年龄(Q1, Q3)为72(24,216)个月。26例(25%)患儿入组时血管内容积低。与正常容积状态相比,低容积状态的平均(SD) IVC/Ao指数较低[0.74 (0.2)vs 0.83 (0.1)];p = 0.090]。IVC/Ao指数与心率(r = -0.29, P = 0.003)、平均动脉压(r = 0.23, P = 0.018)相关性较弱。IVC/Ao指数不是容积状态的独立预测因子(OR = 0.04, P = 0.331)。平均(SD) IVC/Ao指数从复发到缓解显著增加[分别为0.94(0.1)比1.05 (0.2);p = 0.001]。结论:IVC/Ao指数在复发时低于缓解时,并且不能独立预测低血管内容积状态。
{"title":"Inferior Vena Cava/Aorta Diameter Index for the Evaluation of Intravascular Volume Status in Children with Idiopathic Nephrotic Syndrome.","authors":"Anshuman Saha, A P Anila, K V Pavan, Arpana Iyengar, Anil Vasudevan","doi":"10.1007/s13312-025-00154-x","DOIUrl":"10.1007/s13312-025-00154-x","url":null,"abstract":"<p><strong>Objectives: </strong>To correlate the inferior vena cava/aorta diameter (IVC/Ao index) in children with nephrotic syndrome with clinical indicators of volume status, and to compare the IVC/Ao index between children in relapse and in remission.</p><p><strong>Methods: </strong>This prospective longitudinal study included children aged 2-18 years presenting with relapsed nephrotic syndrome. Low intravascular volume status was diagnosed if two of the three criteria (tachycardia, hypotension, prolonged capillary filling time) were present. Sonographic measurements of the IVC and aorta diameter were obtained by a single observer at recruitment and after achieving remission.</p><p><strong>Results: </strong>One hundred and three children (73 boys) with a median (Q1, Q3) age 72 (24, 216) months were recruited. 26 (25%) children had low intravascular volume at recruitment. The mean (SD) IVC/Ao index was lower in low volume status compared to normal volume status [0.74 (0.2) vs 0.83 (0.1); P = 0.090]. The correlation between IVC/Ao index and heart rate (r = -0.29, P = 0.003) and mean arterial pressure (r = 0.23, P = 0.018) was weak. IVC/Ao index was not an independent predictor of volume status (OR = 0.04, P = 0.331). The mean (SD) IVC/Ao index increased significantly from when in relapse to remission [0.94 (0.1) vs 1.05 (0.2), respectively; P = 0.001].</p><p><strong>Conclusions: </strong>The IVC/Ao index was lower in relapse than in remission, and did not predict low intravascular volume status independently.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"113-117"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144788931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-17DOI: 10.1007/s13312-025-00210-6
K H Padma Priya, Janani Sankar
{"title":"Extra-Intestinal Salmonellosis Presenting as Infected Ovarian Teratoma in an Adolescent with Prolonged Fever.","authors":"K H Padma Priya, Janani Sankar","doi":"10.1007/s13312-025-00210-6","DOIUrl":"10.1007/s13312-025-00210-6","url":null,"abstract":"","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"139-140"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145540645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-16DOI: 10.1007/s13312-025-00211-5
Aditi Das, Abhijeet Saha, Rachita Singh Dhull
An observational hospital-based study included 50 children aged 1-18 years with chronic kidney disease (CKD) to ascertain the prevalence of hypothyroidism. Out of 50 enrolled cases 13 had hypothyroidism (serum free thyroxine < 0.93 ng/dL and thyroid stimulating hormone > 5.2 mIU/L). The incidence of hypothyroidism was 23% (3/13) in CKD stage 2/3, 27% (10/37) in CKD stage ≥ 4. Hypothyroidism was present in 20% patients having spot urinary protein to creatinine ratio (UP:UC) between 0.2 and < 2, and 39.1% with UP:UC > 2. Hypothyroidism was more common in children with advanced CKD and those with greater proteinuria. No child had detectable thyroid peroxidase antibodies.
{"title":"Hypothyroidism in Children with Chronic Kidney Disease: An Observational Study.","authors":"Aditi Das, Abhijeet Saha, Rachita Singh Dhull","doi":"10.1007/s13312-025-00211-5","DOIUrl":"10.1007/s13312-025-00211-5","url":null,"abstract":"<p><p>An observational hospital-based study included 50 children aged 1-18 years with chronic kidney disease (CKD) to ascertain the prevalence of hypothyroidism. Out of 50 enrolled cases 13 had hypothyroidism (serum free thyroxine < 0.93 ng/dL and thyroid stimulating hormone > 5.2 mIU/L). The incidence of hypothyroidism was 23% (3/13) in CKD stage 2/3, 27% (10/37) in CKD stage ≥ 4. Hypothyroidism was present in 20% patients having spot urinary protein to creatinine ratio (UP:UC) between 0.2 and < 2, and 39.1% with UP:UC > 2. Hypothyroidism was more common in children with advanced CKD and those with greater proteinuria. No child had detectable thyroid peroxidase antibodies.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"118-120"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145300087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1007/s13312-026-00279-7
Nirmalya Roy Moulik, Chetan Dhamne, Ramandeep Singh Arora
{"title":"Immunotherapy in Pediatric Oncology in India: A Nationwide Survey Assessing Practices, Perceptions, and Barriers Among Pediatric Oncologists.","authors":"Nirmalya Roy Moulik, Chetan Dhamne, Ramandeep Singh Arora","doi":"10.1007/s13312-026-00279-7","DOIUrl":"https://doi.org/10.1007/s13312-026-00279-7","url":null,"abstract":"","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The 2025 Consensus on Science with Treatment Recommendations summary developed by the Neonatal Life Support Task Force of the International Liaison Committee on Resuscitation includes recommendations on neonatal resuscitation issued between 2021 and 2025. Major updates address umbilical cord management at birth, thermoregulation and other initial steps of resuscitation, interfaces and devices for providing positive pressure ventilation, oxygen therapy during neonatal resuscitation, the use of video laryngoscopy for endotracheal intubation, and the application of monitoring devices in the delivery room. Several good practice statements have been added, while certain previous recommendations such as the use of sodium bicarbonate in the delivery room have been withdrawn.
{"title":"2025 ILCOR Neonatal Life Support CoSTR: Key Updates for Clinicians.","authors":"Pratima Anand, Somashekhar Nimbalkar, Viraraghavan Vadakkencherry Ramaswamy","doi":"10.1007/s13312-025-00261-9","DOIUrl":"https://doi.org/10.1007/s13312-025-00261-9","url":null,"abstract":"<p><p>The 2025 Consensus on Science with Treatment Recommendations summary developed by the Neonatal Life Support Task Force of the International Liaison Committee on Resuscitation includes recommendations on neonatal resuscitation issued between 2021 and 2025. Major updates address umbilical cord management at birth, thermoregulation and other initial steps of resuscitation, interfaces and devices for providing positive pressure ventilation, oxygen therapy during neonatal resuscitation, the use of video laryngoscopy for endotracheal intubation, and the application of monitoring devices in the delivery room. Several good practice statements have been added, while certain previous recommendations such as the use of sodium bicarbonate in the delivery room have been withdrawn.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146051803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1007/s13312-026-00275-x
Saphibanrisa Rea Shabong, Devendra Mishra, Monica Juneja, Madiha Rehman, Manu Kumar Shetty, Kumar Harshvardhan
Objective: To assess the behavioral adverse effects associated with the use of levetiracetam in drug-naïve children with epilepsy, either as monotherapy or as part of anti-seizure medications polytherapy.
Methods: This prospective cohort study was conducted in the pediatrics department of a public hospital from October 3, 2024, to July 26, 2025. Typically developing children aged 4-12 years with epilepsy were consecutively enrolled, if they were being planned to be initiated on levetiracetam therapy, either as monotherapy or as an add-on therapy. Behavioral problems were assessed prior to starting levetiracetam using Strength and Difficulties Questionnaire (SDQ) and Child Behavior Checklist (CBCL) and repeated at 14 (+ 3) days and 6 (+ 1) weeks of follow-up.
Results: The study included 60 children with mean (SD) age of 7.75 (2.48) years. At enrollment, behavioral problems were not observed in any child (scores in the normal range). Proportion of those with behavioral problems in any sub-domain in either of the tools at follow-up was 3.3% at 14 days and 11.7% (95% CI 5.77-22.18%) at 6 weeks. Behavioral problems based on total scores, of either tool, were present in 6.7% (95% CI 2.6-16.0%) at 6-week follow-up. Behavioral adverse effects were found to be statistically associated with use of higher doses of levetiracetam (> 30 mg/kg/day), with dose and total CBCL scores [r (95% CI) = 0.542 (0.33-0.70); P < 0.001] and total SDQ scores [r (95% CI) = 0.515 (0.30-0.68); P < 0.001] showing significant correlation. The discontinuation rate was 1.7% (n = 1).
Conclusion: There is a need of close surveillance for neurobehavioral morbidity in children with epilepsy receiving levetiracetam, especially those receiving high doses.
目的:评估左乙拉西坦在drug-naïve儿童癫痫患者中使用的不良行为,无论是作为单一治疗还是作为抗癫痫药物综合治疗的一部分。方法:于2024年10月3日至2025年7月26日在某公立医院儿科进行前瞻性队列研究。正常发育的4-12岁癫痫患儿被连续纳入,如果他们计划开始使用左乙拉西坦治疗,无论是作为单一治疗还是作为附加治疗。使用力量与困难问卷(SDQ)和儿童行为检查表(CBCL)评估左乙拉西坦开始治疗前的行为问题,并在随访14(+ 3)天和6(+ 1)周时重复。结果:本研究纳入60例儿童,平均(SD)年龄7.75(2.48)岁。在入学时,没有观察到任何孩子的行为问题(分数在正常范围内)。在随访中,在任何一种工具的任何子领域中存在行为问题的比例在14天时为3.3%,在6周时为11.7% (95% CI 5.77-22.18%)。在6周的随访中,基于任一工具总分的行为问题发生率为6.7% (95% CI 2.6-16.0%)。行为不良反应与使用高剂量左乙拉西坦(> ~ 30mg /kg/天)有统计学关联,剂量和总CBCL评分[r (95% CI) = 0.542 (0.33 ~ 0.70);结论:需要密切监测癫痫患儿左乙拉西坦,特别是大剂量左乙拉西坦的神经行为发病情况。
{"title":"Behavioral Adverse Effects During Initial Six Weeks of Levetiracetam Therapy in Children with Epilepsy: A Prospective Cohort Study.","authors":"Saphibanrisa Rea Shabong, Devendra Mishra, Monica Juneja, Madiha Rehman, Manu Kumar Shetty, Kumar Harshvardhan","doi":"10.1007/s13312-026-00275-x","DOIUrl":"https://doi.org/10.1007/s13312-026-00275-x","url":null,"abstract":"<p><strong>Objective: </strong>To assess the behavioral adverse effects associated with the use of levetiracetam in drug-naïve children with epilepsy, either as monotherapy or as part of anti-seizure medications polytherapy.</p><p><strong>Methods: </strong>This prospective cohort study was conducted in the pediatrics department of a public hospital from October 3, 2024, to July 26, 2025. Typically developing children aged 4-12 years with epilepsy were consecutively enrolled, if they were being planned to be initiated on levetiracetam therapy, either as monotherapy or as an add-on therapy. Behavioral problems were assessed prior to starting levetiracetam using Strength and Difficulties Questionnaire (SDQ) and Child Behavior Checklist (CBCL) and repeated at 14 (+ 3) days and 6 (+ 1) weeks of follow-up.</p><p><strong>Results: </strong>The study included 60 children with mean (SD) age of 7.75 (2.48) years. At enrollment, behavioral problems were not observed in any child (scores in the normal range). Proportion of those with behavioral problems in any sub-domain in either of the tools at follow-up was 3.3% at 14 days and 11.7% (95% CI 5.77-22.18%) at 6 weeks. Behavioral problems based on total scores, of either tool, were present in 6.7% (95% CI 2.6-16.0%) at 6-week follow-up. Behavioral adverse effects were found to be statistically associated with use of higher doses of levetiracetam (> 30 mg/kg/day), with dose and total CBCL scores [r (95% CI) = 0.542 (0.33-0.70); P < 0.001] and total SDQ scores [r (95% CI) = 0.515 (0.30-0.68); P < 0.001] showing significant correlation. The discontinuation rate was 1.7% (n = 1).</p><p><strong>Conclusion: </strong>There is a need of close surveillance for neurobehavioral morbidity in children with epilepsy receiving levetiracetam, especially those receiving high doses.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}